Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 65862-190

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 65862-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

This is a description for a pharmaceutical product containing Cyclobenzaprine Hydrochloride Tablets, manufactured by Aurobindo Pharma USA, Inc. It is a bulk package of 100 tablets, each film-coated tablet containing 5mg of Cyclobenzaprine hydrochloride USP. It is advised to be dispensed in a well-closed container and stored at 20°to 25°C with excursions permitted to 15°to 30°C. Usual adult dosages are recommended to be one tablet (5mg) three times a day. However, further information can be obtained from the accompanying product information.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

FDA Label Image

Chemical Structure (Cyclobenz Str)

Not-Available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.